biotechNew
Xaira Therapeutics
AI-first drug discovery built on generative biology
weight 0.0Flux 62▴PaidLaunched 2026-06
💸 No earnings reported yet
What it is
Heavily funded biotech (launched with ~$1B) combining generative AI models — including RFdiffusion-lineage protein design from David Baker's lab — with large-scale data generation to discover medicines.
How AI plugs in
Generative and predictive AI across molecular design and target biology drive the full discovery pipeline.
★ Reviews
No reviews yet — be the first.Your rating